Phenytoin use in elderly nursing home residents

American Journal Geriatric Pharmacotherapy

Volumn 1, Issue 2, 2003, Pages 90-95

  Birnbaum, Angela K ^a   Hardie, Nancy A ^a   Conway, Jeannine M ^a   Bowers, Sandra E ^a   Lackner, Thomas E ^a   Graves, Nina M ^a   Leppik, Ilo E ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MINCEP Epilepsy Care   (United States)

Author keywords

Aged; Elderly; Epilepsy; Nursing home; Phenytoin

Indexed keywords

AMIODARONE; CARBAMAZEPINE; CIMETIDINE; CLARITHROMYCIN; COTRIMOXAZOLE; DEXTROPROPOXYPHENE; DILTIAZEM; FLUCONAZOLE; FLUINDOSTATIN; FLUOXETINE; FLURBIPROFEN; FLUVOXAMINE; ISONIAZID; METRONIDAZOLE; OMEPRAZOLE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; RIFABUTIN; RIFAMPICIN; SERTRALINE; TICLOPIDINE; VALPROIC ACID; ANTICONVULSIVE AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG USE; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNITED STATES; AGE; CLINICAL PRACTICE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPILEPSY; HOME FOR THE AGED; INFORMATION PROCESSING; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; EPILEPSY; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PHENYTOIN; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS;

EID: 9644258008     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1543-5946(03)90005-5     Document Type: Article

References (20)

1. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Arch Fam Med. 1994;3:589-598.
2. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: Effect of age, gender, and comedication on patterns of use. Epilepsia. 1998;39:1083-1087.
3. Garrard J, Cloyd J, Gross C, et al. Factors associated with antiepileptic drug use among elderly nursing home residents. J Gerontol A Biol Sci Med Sci. 2000;55:M384-M392.
4. Strahan G. An overview of nursing homes and their current residents: Data from the 1995 National Nursing Home Survey. Adv Data. 1997;280:1-12.
5. Moore SR, Jones JK. Adverse drug reaction surveillance in the geriatric population: A preliminary view. In: Moore SR, Teal TW, eds. Geriatric Drug Use: Clinical & Social Perspectives. New York: Pergamon Press; 1985:70-77.
6. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109:87-94.
7. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-1116.
8. Schachter SC, Cramer GW, Thompson GD, et al. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc. 1998;46:1137-1141.
9. Leppik IE. Drug treatment of epilepsy. In: Johnson TR, ed. Current Therapy in Neurological Disease. Philadelphia: BC Decker; 1985:41-46.
10. Mooradian AD, Hernandez L, Tamai IC, Marshall C. Variability of serum phenytoin concentrations in nursing home patients. Arch Intern Med. 1989;149:890-892.
11. Birnbaum A, Hardie NA, Leppik IE, et al. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology. 2003;60:555-559.
12. Cook PJ, Flanagan R, James IM. Diazepam tolerance: Effect of age, regular sedation, and alcohol. Br Med J (Clin Res Ed). 1984;289:351-353.
13. Cloyd JC, Birnbaum AK, Graves NM, et al. Possible gender effect in phenytoin pharmacokinetics in epilepsy patients. Epilepsia. 2000;41(Suppl 7):231. Abstract 3.220.
14. Sherwin AL, Loynd JS, Bock GW, Sokolowski CD. Effects of age, sex, obesity, and pregnancy on plasma diphenylhydantoin levels. Epilepsia. 1974;15:507-521.
15. Meyer MC, Straughn AB, Mhatre RM, et al. Variability in the bioavailability of phenytoin capsules in males and females. Pharm Res. 2001;18:394-397.
16. Bauer LA, Blouin RA. Age and phenytoin kinetics in adult epileptics. Clin Pharmacol Ther. 1982;31:301-304.
17. Valodia P, Seymour MA, Miller R, et al. Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa. Ther Drug Monit. 1999;21:57-62.
18. Lunde PK, Rane A, Yaffe SJ, et al. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin Pharmacol Ther. 1970;11:846-855.
19. Hooper WD, Bochner F, Eadie MJ, Tyrer JH. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease. Clin Pharmacol Ther. 1974;15:276-282.
20. Arnold K, Gerber N. The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther. 1970;11:121-134.